Centiva Capital, LP Adma Biologics, Inc. Transaction History
Centiva Capital, LP
- $4.65 Billion
- Q4 2024
A detailed history of Centiva Capital, LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 17,337 shares of ADMA stock, worth $280,339. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,337Holding current value
$280,339% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$301 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$294 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$240 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$183 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$89.5 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.18B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...